Bovine Mastitis Market Trends: Focus on Antibiotic-Free Therapies
Bovine Mastitis Market Trends: Focus on Antibiotic-Free Therapies
The bovine mastitis market is experiencing significant growth, driven by rising disease prevalence, increased dairy production, and advancements in diagnostic and treatment methods. This article delves into the key aspects shaping the market landscape.
In 2019, the global bovine mastitis market was valued at USD 1.23 billion and is expected to grow to USD 1.84 billion by 2027, reflecting a compound annual growth rate (CAGR) of 5.2% over the forecast period. North America led the market in 2019, accounting for a dominant share of 32.52%.
Zoetis (New Jersey, U.S.)
Merck & Co., Inc. (MSD Animal Health) (New Jersey, U.S.)
Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany)
Bayer AG (Leverkusen, Germany)
Elanco (Indiana, U.S.)
Ceva (Libourne, France)
West Way Health (Galway, Ireland)
Others
In April 2021, Boehringer Ingelheim expanded its dairy mastitis portfolio by introducing the blue Ubroseal internal teat sealant. This product aims to prevent new intramammary infections during the dry period, enhancing udder health and milk quality.
Drivers:
Increasing prevalence of bovine mastitis, leading to economic losses in the dairy industry.
Growing demand for dairy products, necessitating improved animal health management.
Advancements in diagnostic tools and treatment options, including non-antibiotic therapies.
Restraints:
Rising concerns over antibiotic resistance, prompting regulatory restrictions on antibiotic use.
High costs associated with advanced diagnostic equipment and alternative treatments.
The market report encompasses a comprehensive analysis of the bovine mastitis market, including segmentation by type, product, route of administration, therapy, and region. It provides insights into market size, growth trends, competitive landscape, and future outlook.
The bovine mastitis market is moderately competitive, with key players focusing on product innovation, strategic collaborations, and expansion into emerging markets. Companies are investing in research and development to introduce effective and sustainable treatment options.
By Type:
Clinical Mastitis: Dominates the market due to visible symptoms and immediate economic impact.
Sub-Clinical Mastitis: Expected to grow at a faster rate, driven by advancements in diagnostic technologies.
By Product:
Antibiotics
Vaccines
Non-Antibiotic Therapies
Diagnostics
Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/bovine-mastitis-market-103482
By Route of Administration:
Intra-Mammary
Systemic
By Therapy:
Lactating Period
Dry Period
North America: Holds a significant market share, attributed to the adoption of intramammary infusion products and the presence of leading market players.
Europe: Expected to witness substantial growth due to collaborations among key players and the launch of innovative mastitis treatments.
Asia-Pacific: Anticipated to exhibit the fastest growth, driven by a large cattle population, increasing incidence of mastitis, and government initiatives promoting animal health.
The bovine mastitis market is poised for continued growth, with a focus on sustainable and effective treatment options. The integration of advanced diagnostic tools, such as rapid on-farm detection devices, and the development of non-antibiotic therapies are expected to shape the future of the market. Additionally, increasing awareness among farmers and regulatory support will further drive market expansion.
About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.
Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve sustainable growth. Our experienced analysts and consultants use leading research methodologies to provide comprehensive market assessments enriched with relevant data.
At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and recommendations that help them navigate technological and market changes. Our consulting services are designed to help companies uncover hidden opportunities and address competitive challenges.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com